Success Metrics

Clinical Success Rate
89.5%

Based on 34 completed trials

Completion Rate
89%(34/38)
Active Trials
4(6%)
Results Posted
32%(11 trials)
Terminated
4(6%)

Phase Distribution

Ph phase_4
15
24%
Ph not_applicable
13
21%
Ph phase_2
12
19%
Ph phase_1
7
11%
Ph phase_3
12
19%

Phase Distribution

7

Early Stage

12

Mid Stage

27

Late Stage

Phase Distribution59 total trials
Phase 1Safety & dosage
7(11.9%)
Phase 2Efficacy & side effects
12(20.3%)
Phase 3Large-scale testing
12(20.3%)
Phase 4Post-market surveillance
15(25.4%)
N/ANon-phased studies
13(22.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.1%

34 of 43 finished

Non-Completion Rate

20.9%

9 ended early

Currently Active

4

trials recruiting

Total Trials

63

all time

Status Distribution
Active(6)
Completed(34)
Terminated(9)
Other(14)

Detailed Status

Completed34
unknown14
Withdrawn5
Terminated4
Recruiting3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
63
Active
4
Success Rate
89.5%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (11.9%)
Phase 212 (20.3%)
Phase 312 (20.3%)
Phase 415 (25.4%)
N/A13 (22.0%)

Trials by Status

terminated46%
withdrawn58%
not_yet_recruiting23%
active_not_recruiting12%
completed3454%
recruiting35%
unknown1422%

Recent Activity

Clinical Trials (63)

Showing 20 of 63 trialsScroll for more
NCT05139238Phase 4

Postpartum Hypertension Study

Terminated
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT03976063Phase 3

Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation

Active Not Recruiting
NCT04755764

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Recruiting
NCT06915792Phase 4

PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

Not Yet Recruiting
NCT00817037Phase 2

Sitaxsentan in Proteinuric Chronic Kidney Disease

Completed
NCT05955040Phase 2

Treatment of Elevated Blood Pressures in Early Pregnancy

Terminated
NCT03949478Phase 2

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

Recruiting
NCT06265415Not Applicable

Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine

Not Yet Recruiting
NCT00810732Phase 2

Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects

Completed
NCT05520021Not Applicable

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

Unknown
NCT02438371Phase 4

Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor

Terminated
NCT03129945Not Applicable

Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor

Completed
NCT03542552Phase 3

Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa

Completed
NCT02885558Not Applicable

Role of Calcium Channels in Vascular Function

Completed
NCT03506724Phase 4

Response to Anti-hypertensives in Pregnant and Postpartum Patients

Completed
NCT02531490Phase 4

Early Vascular Adjustments During Hypertensive Pregnancy

Unknown
NCT02132533Phase 3

Nifedipine for Acute Tocolysis of Preterm Labor

Completed
NCT04288219Not Applicable

Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema

Unknown
NCT04404686Phase 2

Vaginal Indomethacin for Preterm Labor

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
63